On Friday, Puma Biotechnology Inc (NASDAQ: PBYI) opened higher 22.24% from the last session, before settling in for the closing price of $4.9. Price fluctuations for PBYI have ranged from $2.32 to $6.07 over the past 52 weeks.
Company’s average yearly earnings per share was noted -11.61% at the time writing. With a float of $38.02 million, this company’s outstanding shares have now reached $50.38 million.
Puma Biotechnology Inc (PBYI) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Puma Biotechnology Inc is 24.55%, while institutional ownership is 57.73%. The most recent insider transaction that took place on Jul 18 ’25, was worth 90,909. In this transaction Director of this company sold 27,000 shares at a rate of $3.37, taking the stock ownership to the 41,850 shares. Before that another transaction happened on Jul 18 ’25, when Company’s Director proposed sale 27,000 for $3.37, making the entire transaction worth $90,909.
Puma Biotechnology Inc (PBYI) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.14) by 0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
Puma Biotechnology Inc (NASDAQ: PBYI) Trading Performance Indicators
Check out the current performance indicators for Puma Biotechnology Inc (PBYI). In the past quarter, the stock posted a quick ratio of 1.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.42. Likewise, its price to free cash flow for the trailing twelve months is 7.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.19 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of Puma Biotechnology Inc (PBYI)
Compared to the last year’s volume of 0.49 million, its volume of 0.88 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 42.23%.
During the past 100 days, Puma Biotechnology Inc’s (PBYI) raw stochastic average was set at 97.37%, which indicates a significant increase from 95.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.02, while its 200-day Moving Average is $3.80. Nevertheless, the first resistance level for the watch stands at $6.34 in the near term. At $6.69, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.34. If the price goes on to break the first support level at $5.34, it is likely to go to the next support level at $4.69. Now, if the price goes above the second support level, the third support stands at $4.34.
Puma Biotechnology Inc (NASDAQ: PBYI) Key Stats
There are currently 50,371K shares outstanding in the company with a market cap of 301.84 million. Presently, the company’s annual sales total 230,470 K according to its annual income of 30,280 K. Last quarter, the company’s sales amounted to 52,440 K and its income totaled 5,860 K.
